Liu Jingwei, Zhang Siyi, Cao Liangzi, Zhang Naijin, Guo Qiqiang, Zou Yu, Yang Ruohan, Dong Shiyuan, Zheng Lixia, Xiao Yutong, Wang Yubang, Lu Songming, Jiang Pengcheng, Zhou Keshen, Chen Shu, Chen Di, Li Hao, Zhang Ying, Sheng Ren, Xing Chengzhong, Song Xiaoyu, Wang Zhenning, Cao Liu
The College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang, Liaoning, China.
Key Laboratory of Cell Biology of Ministry of Public Health, Key Laboratory of Medical Cell Biology of Ministry of Education, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors (China Medical University), Ministry of Education, Liaoning Province Collaborative Innovation Center of Aging Related Disease Diagnosis and Treatment and Prevention, China Medical University, Shenyang, Liaoning, China.
Oncogene. 2025 May 2. doi: 10.1038/s41388-025-03428-7.
PARP1 initiates DNA repair pathways including single-strand break repair (SSBR) by recruiting multiple DNA repair factors via poly ADP-ribosylation (PARylation) of target proteins. However, how PARP1 is stabilized and activated to promote DNA damage repair remains unclear. Here we report that DNA damage generates a ROS signal, which triggers USP10 to interact with and stabilize PARP1 by deubiquitinating the K418 site in an ATM-dependent manner. In turn, PARP1 mediates PARylation of USP10 at amino acid residues D634, D645, and E648, which further promotes the deubiquitination activity of USP10 and DNA damage response to form a positive feedback loop. PARP1 is highly expressed in breast cancer tissues and positively correlates with USP10 protein levels. Moreover, breast cancer cells treated with a USP10 inhibitor show increased sensitivity to PARP1 inhibitor both in vivo and in vitro. Overall, our results unravel that the deubiquitination-PARylation positive feedback loop of the USP10-PARP1 axis promotes DNA damage repair, which might contribute to the improvement of PARP1 inhibitor efficacy in breast cancer treatment.
PARP1通过对靶蛋白进行多聚ADP核糖基化(PARylation)募集多种DNA修复因子,从而启动包括单链断裂修复(SSBR)在内的DNA修复途径。然而,PARP1如何被稳定和激活以促进DNA损伤修复仍不清楚。在此我们报告,DNA损伤产生一个ROS信号,该信号触发USP10以ATM依赖的方式与PARP1相互作用并通过去泛素化K418位点来稳定PARP1。反过来,PARP1介导USP10在氨基酸残基D634、D645和E648处的PARylation,这进一步促进USP10的去泛素化活性和DNA损伤反应,从而形成一个正反馈环。PARP1在乳腺癌组织中高表达,且与USP10蛋白水平呈正相关。此外,用USP10抑制剂处理的乳腺癌细胞在体内和体外对PARP1抑制剂均表现出更高的敏感性。总体而言,我们的结果揭示了USP10 - PARP1轴的去泛素化 - PARylation正反馈环促进DNA损伤修复,这可能有助于提高PARP1抑制剂在乳腺癌治疗中的疗效。